Salarius Pharmaceuticals
SLRX
SLRX
29 hedge funds and large institutions have $10.2M invested in Salarius Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
55% less capital invested
Capital invested by funds: $22.8M → $10.2M (-$12.6M)
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$518K | |
| 2 | +$162K | |
| 3 | +$151K | |
| 4 |
BlackRock
New York
|
+$142K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$130K |
Top Sellers
| 1 | -$1.88M | |
| 2 | -$1.85M | |
| 3 | -$1.04M | |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$633K |
| 5 |
Renaissance Technologies
New York
|
-$352K |